Sung Ji Nam
Stock Analyst at Scotiabank
(4.12)
# 1,170
Out of 4,479 analysts
41
Total ratings
54.05%
Success rate
12.95%
Average return
Main Sectors:
15 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXAS Exact Sciences | Initiates: Sector Outperform | $70 | $43.17 | +62.15% | 1 | Jun 27, 2024 | |
| MYGN Myriad Genetics | Initiates: Sector Outperform | $29 | $24.76 | +17.12% | 1 | Jun 27, 2024 | |
| TWST Twist Bioscience | Maintains: Sector Outperform | $43 → $48 | $47.32 | +1.44% | 3 | May 6, 2024 | |
| ILMN Illumina | Maintains: Sector Outperform | $185 → $176 | $105.51 | +66.81% | 5 | May 6, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Sector Outperform | $15 → $8 | $1.28 | +525.00% | 2 | Apr 18, 2024 | |
| BNGO Bionano Genomics | Maintains: Sector Outperform | $7 → $6 | $0.57 | +952.26% | 4 | Mar 7, 2024 | |
| CSTL Castle Biosciences | Maintains: Sector Outperform | $33 → $37 | $21.26 | +74.04% | 3 | Mar 1, 2024 | |
| OLK Olink Holding AB (publ) | Downgrades: Sector Perform | n/a | $25.73 | - | 3 | Oct 18, 2023 | |
| TKNO Alpha Teknova | Assumes: Buy | $6 | $1.23 | +387.80% | 2 | Jun 29, 2023 | |
| CDNA CareDx | Downgrades: Neutral | n/a | $14.90 | - | 2 | May 11, 2023 | |
| GH Guardant Health | Initiates: Sector Outperform | $36 | $28.87 | +24.70% | 2 | Jan 5, 2023 | |
| VCYT Veracyte | Initiates: Sector Outperform | $33 | $21.26 | +55.22% | 2 | Jan 5, 2023 | |
| ADPT Adaptive Biotechnologies | Initiates: Sector Outperform | $15 | $3.37 | +345.10% | 1 | Jan 5, 2023 | |
| TMO Thermo Fisher | Maintains: Buy | $718 | $533.93 | +34.47% | 8 | Feb 2, 2022 | |
| FLGT Fulgent Genetics | Downgrades: Neutral | n/a | $19.98 | - | 2 | Nov 24, 2020 |
Exact Sciences
Jun 27, 2024
Initiates: Sector Outperform
Price Target: $70
Current: $43.17
Upside: +62.15%
Myriad Genetics
Jun 27, 2024
Initiates: Sector Outperform
Price Target: $29
Current: $24.76
Upside: +17.12%
Twist Bioscience
May 6, 2024
Maintains: Sector Outperform
Price Target: $43 → $48
Current: $47.32
Upside: +1.44%
Illumina
May 6, 2024
Maintains: Sector Outperform
Price Target: $185 → $176
Current: $105.51
Upside: +66.81%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Sector Outperform
Price Target: $15 → $8
Current: $1.28
Upside: +525.00%
Bionano Genomics
Mar 7, 2024
Maintains: Sector Outperform
Price Target: $7 → $6
Current: $0.57
Upside: +952.26%
Castle Biosciences
Mar 1, 2024
Maintains: Sector Outperform
Price Target: $33 → $37
Current: $21.26
Upside: +74.04%
Olink Holding AB (publ)
Oct 18, 2023
Downgrades: Sector Perform
Price Target: n/a
Current: $25.73
Upside: -
Alpha Teknova
Jun 29, 2023
Assumes: Buy
Price Target: $6
Current: $1.23
Upside: +387.80%
CareDx
May 11, 2023
Downgrades: Neutral
Price Target: n/a
Current: $14.90
Upside: -
Guardant Health
Jan 5, 2023
Initiates: Sector Outperform
Price Target: $36
Current: $28.87
Upside: +24.70%
Veracyte
Jan 5, 2023
Initiates: Sector Outperform
Price Target: $33
Current: $21.26
Upside: +55.22%
Adaptive Biotechnologies
Jan 5, 2023
Initiates: Sector Outperform
Price Target: $15
Current: $3.37
Upside: +345.10%
Thermo Fisher
Feb 2, 2022
Maintains: Buy
Price Target: $718
Current: $533.93
Upside: +34.47%
Fulgent Genetics
Nov 24, 2020
Downgrades: Neutral
Price Target: n/a
Current: $19.98
Upside: -